DNA methylation as an epigenetic signature predictive of response to neodjuvant treatment in TNBC patients

Authors :: Manel Esteller
Juan Sandoval
Angel Díaz-Lagares
Inés González-Barrallo
Ana Lluch
Octavio Burgues
Begoña Pineda
Jose Alejandro Perez-Fidalgo
Pilar Eroles
Ana B. Crujeiras
Source :: Journal of Clinical Oncology. 36:e12658-e12658
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e12658Background: Prediction of response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) patients is an unmet medical need. NAC with anthracyclines/taxanes achieves about ...

Subjects :: 0301 basic medicine
Cancer Research
Chemotherapy
business.industry
medicine.medical_treatment
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Breast cancer
Oncology
030220 oncology & carcinogenesis
DNA methylation
medicine
Cancer research
Epigenetics
business

Full Text Access

Tools